Abstract

IntroductionTumors are continuously evolving biological systems which can be monitored by medical imaging. Previous studies only focus on single timepoint images, whether the performance could be further improved by using serial noncontrast CT imaging obtained during nodule follow-up management remains unclear. In this study, we evaluated DL model for predicting tumor invasiveness of GGNs through analyzing time series CT imagesMethodsA total of 168 pathologically confirmed GGN cases (48 noninvasive lesions and 120 invasive lesions) were retrospectively collected and randomly assigned to the development dataset (n = 123) and independent testing dataset (n = 45). All patients underwent consecutive noncontrast CT examinations, and the baseline CT and 3-month follow-up CT images were collected. The gross region of interest (ROI) patches containing only tumor region and the full ROI patches including both tumor and peritumor regions were cropped from CT images. A baseline model was built on the image features and demographic features. Four DL models were proposed: two single-DL model using gross ROI (model 1) or full ROI patches (model 3) from baseline CT images, and two serial-DL models using gross ROI (model 2) or full ROI patches (model 4) from consecutive CT images (baseline scan and 3-month follow-up scan). In addition, a combined model integrating serial full ROI patches and clinical information was also constructed. The performance of these predictive models was assessed with respect to discrimination and clinical usefulness.ResultsThe area under the curve (AUC) of the baseline model, models 1, 2, 3, and 4 were 0.562 [(95% confidence interval (C)], 0.406~0.710), 0.693 (95% CI, 0.538–0.822), 0.787 (95% CI, 0.639–0.895), 0.727 (95% CI, 0.573–0.849), and 0.811 (95% CI, 0.667–0.912) in the independent testing dataset, respectively. The results indicated that the peritumor region had potential to contribute to tumor invasiveness prediction, and the model performance was further improved by integrating imaging scans at multiple timepoints. Furthermore, the combined model showed best discrimination ability, with AUC, sensitivity, specificity, and accuracy achieving 0.831 (95% CI, 0.690–0.926), 86.7%, 73.3%, and 82.2%, respectively.ConclusionThe DL model integrating full ROIs from serial CT images shows improved predictive performance in differentiating noninvasive from invasive GGNs than the model using only baseline CT images, which could benefit the clinical management of GGNs.

Highlights

  • Tumors are continuously evolving biological systems which can be monitored by medical imaging

  • A total of 168 patients with 168 ground-glass nodules (GGNs) [13 atypical adenomatous hyperplasia (AAH), 107 minimally invasive adenocarcinoma (MIA), 35 adenocarcinoma in situ (AIS), and 13 invasive adenocarcinoma (IAC)] were enrolled, and two consecutive computed tomography (CT) scans within about 3 months (82–109 days, median 93 days) for each patient were used in this study

  • We developed novel deep learning (DL) models to detect the invasiveness of GGNs based on consecutive CT thin-scanned images

Read more

Summary

Introduction

Tumors are continuously evolving biological systems which can be monitored by medical imaging. We evaluated DL model for predicting tumor invasiveness of GGNs through analyzing time series CT images. As HRCT scans of the chest are gradually emerging as part of a routine physical examination, reasonable and necessary management of screening-detected and incidentally detected indeterminate pulmonary nodules is warranted. Persistent lung GGNs may represent noninvasive or invasive adenocarcinoma. Different pathological subtypes of GGNs vary with respect to the surgical approaches and clinical nodule management strategies required. Conservative nodule management is appropriate for noninvasive GGNs, whereas invasive GGNs are suitable for surgical resection. The Fleischner Society Guidelines for management of incidental subsolid nodules was published in 2017 and recommended follow-up intervals ranging from 3 months to several years [3]. Follow-up has a crucial role in clinical decision-making and assessment of surgical indication, and is increasingly recommended by thoracic and pulmonary guidance

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call